Janssen Pharmaceutica N.V., Belgium

CompanyBelgium

Janssen Pharmaceutica N.V., Belgium develops one asset, approved (nicotine in smoking). Mostly small molecule acting on CHRNA4, CHRNB2 and CHRNA7; based in Belgium.

Assets
1
Furthest
Approved
Trials
5
Signals
0

Pipeline

1

  • nicotine

    Nicotinic acetylcholine receptor agonist

    ApprovedSmall moleculeCHRNA4CHRNB2smokingsmoking cessation

Full company profiles: pipeline, trials, funding and people.

See Pro
  • Evidence behind the mechanisms3
  • Trials5
  • Similar companies6

Updated 7 Oct 2026 · 27 sources

Intelligence